• -
  • English
  • English
  • Korean
首頁 > 出版商一覽 > GervanoRA Data Services LLP
出版商
出版商指數
從類別尋找
從地區尋找

GervanoRA Data Services LLP 市場調查資料一覽

日商環球訊息有限公司為GervanoRA Data Services LLP所發行的研究報告代理商, 考慮購買或需要諮詢研究報告時請與我們聯絡。 ≫ 選擇本公司購買的優點

GervanoRA Data Services LLP
GervanoRA Data Services LLP是位於印度果亞的調查報告公司,提供企業聯盟報告、客製化調查報告以及顧問服務。本公司目標在於提供市場最新情報、統計數據、技術情報、關於蘊藏巨大利益成長領域的獨家觀點、競爭框架綜觀圖、未來市場趨勢預測等高完成度的組合式解決方案,以實惠的價格提供候補藥物分析報告、流行病學相關報告、預測、基於臨床試驗資料庫的報告、各國情報、市場與商業機會相關評估報告等內容,持續努力不懈以維持市場領袖地位。本公司透過優秀的團隊合作確保解決方案的品質,與KOL建立合作關係以入手貴重情報的健全體制,獨立開發的大規模資料庫及專精於醫療領域的全球性調查網,活用優異且專業的知識,在世界各國提供獨特的顧問服務。

篩選
標題搜索
結果共70個,以下為1 - 25 排序依 每頁數量
Transient Ischemic Attack - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Transient Ischemic Attack - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069396
出版日期
2022年04月01日
內容資訊
142 Pages
價格
USD 7,000 Sample Availavle
Hemorrhagic Stroke - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Hemorrhagic Stroke - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069395
出版日期
2022年03月21日
內容資訊
186 Pages
價格
USD 7,000 Sample Availavle
Ischemic Stroke - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Ischemic Stroke - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069394
出版日期
2022年03月11日
內容資訊
225 Pages
價格
USD 7,000 Sample Availavle
Stroke - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Stroke - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069393
出版日期
2022年02月19日
內容資訊
391 Pages
價格
USD 11,000 Sample Availavle
Moderate to Severe TBIs - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Moderate to Severe TBIs - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069392
出版日期
2022年01月25日
內容資訊
175 Pages
價格
USD 7,000 Sample Availavle
Concussion - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Concussion - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069391
出版日期
2022年01月15日
內容資訊
150 Pages
價格
USD 7,000 Sample Availavle
Kaposi's Sarcoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Kaposi's Sarcoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069390
出版日期
2021年12月29日
內容資訊
128 Pages
價格
USD 7,000 Sample Availavle
Actinic Keratosis - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Actinic Keratosis - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069389
出版日期
2021年12月24日
內容資訊
132 Pages
價格
USD 7,000 Sample Availavle
Cutaneous T-Cell Lymphoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Cutaneous T-Cell Lymphoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069388
出版日期
2021年12月20日
內容資訊
151 Pages
價格
USD 7,000 Sample Availavle
Merkel Cell Carcinoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Merkel Cell Carcinoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069387
出版日期
2021年12月11日
內容資訊
146 Pages
價格
USD 7,000 Sample Availavle
Squamous Cell Carcinoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Squamous Cell Carcinoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069386
出版日期
2021年12月06日
內容資訊
155 Pages
價格
USD 7,000 Sample Availavle
Basal Cell Carcinoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Basal Cell Carcinoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069385
出版日期
2021年11月30日
內容資訊
170 Pages
價格
USD 7,000 Sample Availavle
Non-Melanoma Skin Cancers - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Non-Melanoma Skin Cancers - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069384
出版日期
2021年11月25日
內容資訊
215 Pages
價格
USD 11,000 Sample Availavle
Melanoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
Melanoma - Epidemiology Based Current (2021) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal Worth Assessments, r-NPV and Pipeline Drugs Analytics H1 2022 Report
出版商
GervanoRA Data Services LLP
商品編碼
1069383
出版日期
2021年11月16日
內容資訊
273 Pages
價格
USD 7,000 Sample Availavle
Seborrheic Dermatitis - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Seborrheic Dermatitis - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
出版商
GervanoRA Data Services LLP
商品編碼
1035550
出版日期
2021年11月06日
內容資訊
210 Pages
價格
USD 7,000 Sample Availavle
Nevoid Basal Cell Carcinoma Syndrome - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Nevoid Basal Cell Carcinoma Syndrome - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
出版商
GervanoRA Data Services LLP
商品編碼
1035549
出版日期
2021年11月02日
內容資訊
175 Pages
價格
USD 7,000 Sample Availavle
Angelman Syndrome - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Angelman Syndrome - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
出版商
GervanoRA Data Services LLP
商品編碼
1035548
出版日期
2021年10月29日
內容資訊
205 Pages
價格
USD 7,000 Sample Availavle
Non-Alcoholic Steatohepatitis - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Non-Alcoholic Steatohepatitis - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
出版商
GervanoRA Data Services LLP
商品編碼
1035547
出版日期
2021年10月26日
內容資訊
180 Pages
價格
USD 7,000 Sample Availavle
Systemic Scleroderma (Sclerosis) - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Systemic Scleroderma (Sclerosis) - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
出版商
GervanoRA Data Services LLP
商品編碼
1035546
出版日期
2021年10月22日
內容資訊
155 Pages
價格
USD 7,000 Sample Availavle
Primary Hyperoxaluria Type 1 - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Primary Hyperoxaluria Type 1 - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
出版商
GervanoRA Data Services LLP
商品編碼
1035545
出版日期
2021年10月19日
內容資訊
170 Pages
價格
USD 7,000 Sample Availavle
Rett Syndrome - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Rett Syndrome - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
出版商
GervanoRA Data Services LLP
商品編碼
1035544
出版日期
2021年10月15日
內容資訊
130 Pages
價格
USD 7,000 Sample Availavle
Chimeric Antigen Receptor (CAR) T-Cell Therapy - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Chimeric Antigen Receptor (CAR) T-Cell Therapy - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
出版商
GervanoRA Data Services LLP
商品編碼
1035543
出版日期
2021年10月12日
內容資訊
325 Pages
價格
USD 11,000 Sample Availavle
Traumatic Brain Injury - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Traumatic Brain Injury - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
出版商
GervanoRA Data Services LLP
商品編碼
1035542
出版日期
2021年10月08日
內容資訊
275 Pages
價格
USD 7,000 Sample Availavle
Erythromelalgia - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Erythromelalgia - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
出版商
GervanoRA Data Services LLP
商品編碼
1035541
出版日期
2021年10月05日
內容資訊
132 Pages
價格
USD 7,000 Sample Availavle
Acute Myeloid Leukemia - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Acute Myeloid Leukemia - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
出版商
GervanoRA Data Services LLP
商品編碼
1024215
出版日期
2021年08月16日
內容資訊
250 Pages
價格
USD 7,000 Sample Availavle